The Medical University of Vienna and Vienna General Hospital perform the first two commercial implants worldwide of Sequana Medical's ALFApump® System
Zurich (ots) - Major milestone achieved in the commercial launch of new technology in the treatment of patients with refractory ascites due to liver cirrhosis. Sequana Medical, the Medical University of Vienna and Vienna General Hospital (AKH Wien) reported that the first two commercial implants worldwide of the ...